Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenli Dong

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Journal of Colloid and Interface Science|February 26, 2026
Mechanochromic and programmable cellulose nanocrystals ionogels for dual-mode ionic skinsWenli Dong, Shouquan Zhan, Xu Wang, et al.
Breast Cancer Research and Treatment|February 22, 2014
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancerYa-Chen Tina Shih, Ying Xu, Wenli Dong, et al.
NPJ Breast Cancer|February 22, 2025
Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancerNina Tamirisa, Wenli Dong, Yu Shen, et al.
Cancer|March 17, 2009
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004Yu Shen, Wenli Dong, Barry W Feig, et al.
Research Square|November 14, 2023
Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted ModelingWenli Dong, Takeo Fujii, Jing Ning, et al.
Scientific Reports|February 15, 2025
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modelingWenli Dong, Takeo Fujii, Jing Ning, et al.
Breast Cancer Research and Treatment|October 10, 2006
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?Yu Shen, Wenli Dong, Francisco J Esteva, et al.
Cancer Medicine|March 19, 2014
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary settingLavinia P Middleton, Nour Sneige, Robin Coyne, et al.
Pain Medicine (Malden, Mass.)|October 11, 2017
Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer PainDhanalakshmi Koyyalagunta, Eduardo Bruera, Mitchell P Engle, et al.
Toxicology and Applied Pharmacology|January 6, 2022
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synucleinJiahong Zhong, Mengfan Li, Jiangping Xu, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Journal of Colloid and Interface Science|February 26, 2026
Mechanochromic and programmable cellulose nanocrystals ionogels for dual-mode ionic skinsWenli Dong, Shouquan Zhan, Xu Wang, et al.
Breast Cancer Research and Treatment|February 22, 2014
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancerYa-Chen Tina Shih, Ying Xu, Wenli Dong, et al.
NPJ Breast Cancer|February 22, 2025
Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancerNina Tamirisa, Wenli Dong, Yu Shen, et al.
Cancer|March 17, 2009
Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004Yu Shen, Wenli Dong, Barry W Feig, et al.
Research Square|November 14, 2023
Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted ModelingWenli Dong, Takeo Fujii, Jing Ning, et al.
Scientific Reports|February 15, 2025
Reassessing estrogen receptor expression thresholds for breast cancer prognosis in HER2-negative patients using shape restricted modelingWenli Dong, Takeo Fujii, Jing Ning, et al.
Breast Cancer Research and Treatment|October 10, 2006
Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?Yu Shen, Wenli Dong, Francisco J Esteva, et al.
Cancer Medicine|March 19, 2014
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary settingLavinia P Middleton, Nour Sneige, Robin Coyne, et al.
Pain Medicine (Malden, Mass.)|October 11, 2017
Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer PainDhanalakshmi Koyyalagunta, Eduardo Bruera, Mitchell P Engle, et al.
Toxicology and Applied Pharmacology|January 6, 2022
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synucleinJiahong Zhong, Mengfan Li, Jiangping Xu, et al.
Pageof 8